首页 > 最新文献

中华消化杂志最新文献

英文 中文
Comparison of esophageal motility between gastroesophageal reflux disease and functional esophageal disorders based on Lyon consensus 基于Lyon共识的胃食管反流病与功能性食管疾病的食管运动比较
Pub Date : 2020-02-15 DOI: 10.3760/CMA.J.ISSN.0254-1432.2020.02.005
Xiaodong Ying, M. Li, Chaoqiong Jin, B. Lyu
Objective To analyze the differences in esophageal motility between patients with gastroesophageal reflux disease (GERD) and functional esophageal disorders by comparing the esophagogastric junction (EGJ) barrier function, esophageal body motor function and results of provocative test. Methods From December 2016 to December 2018, the 100 patients with typical symptoms of GERD, who visited The First Aftiliated Hospifal of Zhejiang Chinese Medical Universtiy wese selected. According to the Rome Ⅳ standand and the Lyon consensus, and the results of endoscopic examination, 24 h multichannel intratuminal impedante pH (MII-pH) monitoring and esophageal high resolution manometry (HRM), the patients were divided into GERD group (n=32), hypersensitivity(RH) group (n=33) and functional heartburn(FH) group (n=35). According to the results of esophageal HRM, the differences in esophageal dynamics among the groups were analyzed. T test, variance analysis and Chi square test were performed for statistical analysis. Results The lower esophageal sphincter (LES) resting pressure of GERD group was lower than that of FH group ((19.37±7.92) mmHg vs. (25.35±12.38) mmHg (1 mmHg=0.133 kPa)); the EGJ-contractile integral of GERD group and RH group was lower than that of FH group ((20.84±21.52) mmHg·cm and (20.72±19.35) mmHg·cm vs. (35.93±36.82) mmHg·cm), and the level of distal contractile integral of GERD group was lower than that of FH group and RH group ((802.35±496.86) mmHg·s·cm vs. (1 316.84±853.92) mmHg·s·cm and (1 141.65±607.93) mmHg·s·cm), and the differences were statistically significant (t=-2.377, -2.069, -2.149, -3.045 and -2.467, all P<0.05). There were no major motility disorders in patients of the three groups. The incidence of ineffective oesophageal motility of GERD group was higher than that of RH group and FH group (62.5%(20/32) vs. 39.4%(13/33) and 25.7%(9/35)), and the differences were statistically significant (χ2=4.440 and 9.214, both P<0.05). Conclusions GERD patients have abnormal esophageal motility, which is mainly manifested by reduced LES resting pressure, decreased EGJ barrier function, and abnormal peristalsis of the esophagus. Patients with RH also have decreased EGJ barrier function. Key words: Gastroesophageal reflux; Functional heartburn; Reflux hypersensitivity; High resolution manometry; Lyon consensus
目的通过比较食管胃交界(EGJ)屏障功能、食管体运动功能及刺激试验结果,分析胃食管反流病(GERD)与功能性食管疾病患者食管运动功能的差异。方法选取2016年12月至2018年12月在浙江中医药大学第一附属医院就诊的100例有典型胃食管反流症状的患者。根据RomeⅣ标准和Lyon共识,结合内镜检查、24 h多通道腔内阻抗pH (MII-pH)监测和食管高分辨率测压(HRM)结果,将患者分为GERD组(n=32)、超敏(RH)组(n=33)和功能性烧心(FH)组(n=35)。根据食道HRM结果,分析各组间食道动力学的差异。采用T检验、方差分析和卡方检验进行统计学分析。结果GERD组食管下括约肌静息压明显低于FH组((19.37±7.92)mmHg vs(25.35±12.38)mmHg (1 mmHg=0.133 kPa);GERD组和RH组egj -收缩积分低于FH组((20.84±21.52)mmHg·cm和(20.72±19.35)mmHg·cm比(35.93±36.82)mmHg·cm), GERD组远端收缩积分低于FH组和RH组((802.35±496.86)mmHg·s·cm比(1 316.84±853.92)mmHg·s·cm和(1 141.65±607.93)mmHg·s·cm),差异均有统计学意义(t=-2.377、-2.069、-2.149、-3.045、-2.467,P均<0.05)。三组患者均无重大运动障碍。GERD组食管运动不良发生率高于RH组和FH组(62.5%(20/32)、39.4%(13/33)、25.7%(9/35),差异有统计学意义(χ2=4.440、9.214,P均<0.05)。结论GERD患者食管运动异常,主要表现为LES静息压降低,EGJ屏障功能下降,食管蠕动异常。RH患者也有EGJ屏障功能下降。关键词:胃食管反流;功能性胃灼热;回流过敏;高分辨率测压法;里昂的共识
{"title":"Comparison of esophageal motility between gastroesophageal reflux disease and functional esophageal disorders based on Lyon consensus","authors":"Xiaodong Ying, M. Li, Chaoqiong Jin, B. Lyu","doi":"10.3760/CMA.J.ISSN.0254-1432.2020.02.005","DOIUrl":"https://doi.org/10.3760/CMA.J.ISSN.0254-1432.2020.02.005","url":null,"abstract":"Objective \u0000To analyze the differences in esophageal motility between patients with gastroesophageal reflux disease (GERD) and functional esophageal disorders by comparing the esophagogastric junction (EGJ) barrier function, esophageal body motor function and results of provocative test. \u0000 \u0000 \u0000Methods \u0000From December 2016 to December 2018, the 100 patients with typical symptoms of GERD, who visited The First Aftiliated Hospifal of Zhejiang Chinese Medical Universtiy wese selected. According to the Rome Ⅳ standand and the Lyon consensus, and the results of endoscopic examination, 24 h multichannel intratuminal impedante pH (MII-pH) monitoring and esophageal high resolution manometry (HRM), the patients were divided into GERD group (n=32), hypersensitivity(RH) group (n=33) and functional heartburn(FH) group (n=35). According to the results of esophageal HRM, the differences in esophageal dynamics among the groups were analyzed. T test, variance analysis and Chi square test were performed for statistical analysis. \u0000 \u0000 \u0000Results \u0000The lower esophageal sphincter (LES) resting pressure of GERD group was lower than that of FH group ((19.37±7.92) mmHg vs. (25.35±12.38) mmHg (1 mmHg=0.133 kPa)); the EGJ-contractile integral of GERD group and RH group was lower than that of FH group ((20.84±21.52) mmHg·cm and (20.72±19.35) mmHg·cm vs. (35.93±36.82) mmHg·cm), and the level of distal contractile integral of GERD group was lower than that of FH group and RH group ((802.35±496.86) mmHg·s·cm vs. (1 316.84±853.92) mmHg·s·cm and (1 141.65±607.93) mmHg·s·cm), and the differences were statistically significant (t=-2.377, -2.069, -2.149, -3.045 and -2.467, all P<0.05). There were no major motility disorders in patients of the three groups. The incidence of ineffective oesophageal motility of GERD group was higher than that of RH group and FH group (62.5%(20/32) vs. 39.4%(13/33) and 25.7%(9/35)), and the differences were statistically significant (χ2=4.440 and 9.214, both P<0.05). \u0000 \u0000 \u0000Conclusions \u0000GERD patients have abnormal esophageal motility, which is mainly manifested by reduced LES resting pressure, decreased EGJ barrier function, and abnormal peristalsis of the esophagus. Patients with RH also have decreased EGJ barrier function. \u0000 \u0000 \u0000Key words: \u0000Gastroesophageal reflux; Functional heartburn; Reflux hypersensitivity; High resolution manometry; Lyon consensus","PeriodicalId":10009,"journal":{"name":"中华消化杂志","volume":"8 1","pages":"87-92"},"PeriodicalIF":0.0,"publicationDate":"2020-02-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"87142968","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Prognostic evaluation of patients with TNM stage I to III gastric cancer by platelet-lymphocyte ratio and neutrophil-lymphocyte ratio 血小板-淋巴细胞比值及中性粒细胞-淋巴细胞比值对TNM I ~ III期胃癌患者预后的评价
Pub Date : 2020-02-15 DOI: 10.3760/CMA.J.ISSN.0254-1432.2020.02.006
Ziyu Zhu, Yimin Wang, Fengke Li, Jialiang Gao, B. Han, Rui Wang, Yingwei Xue
Objective To compare the ability of platelet-lymphocyte ratio (PLR) and neutrophil-lymphocyte ratio (NLR) in evaluating the prognosis of patients with TNM stageⅠto Ⅲ gastric cancer. Methods From May 2001 to December 2013, the clinicopathological data of 645 patients with gastric cancer treated at Harbin Medical University Cancer Hospital were retrospectively analyzed. Chi-square test was used to analyze the differences between NLR, and PLR and clinicopathological characteristics of patients. Kaplan-Meier method and log-rank test were performed to compare the overall survival of patients. Cox proportional hazards regression model was performed to analyze the prognosis of gastric cancer patients. The ability of NLR and PLR to evaluate the prognosis of gastric cancer was compared by receiver operating characteristic curve. Results The cutoff values of PLR and NLR were 141.50 and 1.94, respectively. PLR was associated with gender, resection method, maximum diameter of tumor, whether chemotherapy, T-stage, N-stage, TNM stage, tumor location, white blood cell, hemoglobin, albumin, and whether total gastrectomy (χ2=9.224, 10.577, 28.825, 6.831, 29.059, 28.637, 30.748, 18.023, 24.320, 77.274, 9.021 and 10.745, all P<0.05). NLR were associated with resection method, maximum diameter of tumor, T-stage, N-stage and TNM stage, white blood cell, hemoglobin and albumin (χ2=14.563, 12.092, 22.697, 44.735, 34.151, 7.949, 9.611 and 7.498, all P<0.05). The results of multivariate analysis showed that resection method, whether chemotherapy, T-stage, N-stage, PLR and whether total gastrectomy were all independent risk factors for gastric cancer patients (χ2=23.653, 22.023, 16.697, 24.038, 4.110 and 22.364, all P<0.05). The five-year cumulative survival rate of the patients with PLR<141.50 was higher than that of patients with PLR≥141.50 (55.4% vs. 30.5%), and the difference was statistically significant (χ2=47.968, P<0.01). The AUC value of PLR in prognostic evaluation of gastric cancer was 0.629, which was higher than that of NLR (0.596, P<0.01). Conclusion PLR is better than NLR in the prognostic evaluation of gastric cancer patients. Key words: Stomach neoplasms; Prognosis; Platelet-lymphocyte ratio; Neutrophil-lymphocyte ratio
目的比较血小板淋巴细胞比值(PLR)和中性粒细胞淋巴细胞比值(NLR)对TNM期Ⅰ~Ⅲ胃癌患者预后的评价价值。方法回顾性分析2001年5月至2013年12月在哈尔滨医科大学肿瘤医院治疗的645例胃癌患者的临床病理资料。采用卡方检验分析NLR、PLR与患者临床病理特征的差异。采用Kaplan-Meier法和log-rank检验比较患者的总生存率。采用Cox比例风险回归模型分析胃癌患者的预后。采用受试者工作特征曲线比较NLR和PLR对胃癌预后的评价能力。结果PLR和NLR的临界值分别为141.50和1.94。PLR与性别、切除方式、肿瘤最大直径、是否化疗、t分期、n分期、TNM分期、肿瘤部位、白细胞、血红蛋白、白蛋白、是否全胃切除相关(χ2=9.224、10.577、28.825、6.831、29.059、28.637、30.748、18.023、24.320、77.274、9.021、10.745,P均<0.05)。NLR与切除方式、肿瘤最大直径、t分期、n分期、TNM分期、白细胞、血红蛋白、白蛋白相关(χ2=14.563、12.092、22.697、44.735、34.151、7.949、9.611、7.498,P均<0.05)。多因素分析结果显示,切除方式、是否化疗、t分期、n分期、PLR、是否全胃切除均为胃癌患者的独立危险因素(χ2=23.653、22.023、16.697、24.038、4.110、22.364,P均<0.05)。PLR<141.50的患者5年累积生存率高于PLR≥141.50的患者(55.4%比30.5%),差异有统计学意义(χ2=47.968, P<0.01)。PLR在胃癌预后评价中的AUC值为0.629,高于NLR (0.596, P<0.01)。结论PLR对胃癌患者预后的评价优于NLR。关键词:胃肿瘤;预后;Platelet-lymphocyte比率;Neutrophil-lymphocyte比率
{"title":"Prognostic evaluation of patients with TNM stage I to III gastric cancer by platelet-lymphocyte ratio and neutrophil-lymphocyte ratio","authors":"Ziyu Zhu, Yimin Wang, Fengke Li, Jialiang Gao, B. Han, Rui Wang, Yingwei Xue","doi":"10.3760/CMA.J.ISSN.0254-1432.2020.02.006","DOIUrl":"https://doi.org/10.3760/CMA.J.ISSN.0254-1432.2020.02.006","url":null,"abstract":"Objective \u0000To compare the ability of platelet-lymphocyte ratio (PLR) and neutrophil-lymphocyte ratio (NLR) in evaluating the prognosis of patients with TNM stageⅠto Ⅲ gastric cancer. \u0000 \u0000 \u0000Methods \u0000From May 2001 to December 2013, the clinicopathological data of 645 patients with gastric cancer treated at Harbin Medical University Cancer Hospital were retrospectively analyzed. Chi-square test was used to analyze the differences between NLR, and PLR and clinicopathological characteristics of patients. Kaplan-Meier method and log-rank test were performed to compare the overall survival of patients. Cox proportional hazards regression model was performed to analyze the prognosis of gastric cancer patients. The ability of NLR and PLR to evaluate the prognosis of gastric cancer was compared by receiver operating characteristic curve. \u0000 \u0000 \u0000Results \u0000The cutoff values of PLR and NLR were 141.50 and 1.94, respectively. PLR was associated with gender, resection method, maximum diameter of tumor, whether chemotherapy, T-stage, N-stage, TNM stage, tumor location, white blood cell, hemoglobin, albumin, and whether total gastrectomy (χ2=9.224, 10.577, 28.825, 6.831, 29.059, 28.637, 30.748, 18.023, 24.320, 77.274, 9.021 and 10.745, all P<0.05). NLR were associated with resection method, maximum diameter of tumor, T-stage, N-stage and TNM stage, white blood cell, hemoglobin and albumin (χ2=14.563, 12.092, 22.697, 44.735, 34.151, 7.949, 9.611 and 7.498, all P<0.05). The results of multivariate analysis showed that resection method, whether chemotherapy, T-stage, N-stage, PLR and whether total gastrectomy were all independent risk factors for gastric cancer patients (χ2=23.653, 22.023, 16.697, 24.038, 4.110 and 22.364, all P<0.05). The five-year cumulative survival rate of the patients with PLR<141.50 was higher than that of patients with PLR≥141.50 (55.4% vs. 30.5%), and the difference was statistically significant (χ2=47.968, P<0.01). The AUC value of PLR in prognostic evaluation of gastric cancer was 0.629, which was higher than that of NLR (0.596, P<0.01). \u0000 \u0000 \u0000Conclusion \u0000PLR is better than NLR in the prognostic evaluation of gastric cancer patients. \u0000 \u0000 \u0000Key words: \u0000Stomach neoplasms; Prognosis; Platelet-lymphocyte ratio; Neutrophil-lymphocyte ratio","PeriodicalId":10009,"journal":{"name":"中华消化杂志","volume":"25 1","pages":"93-98"},"PeriodicalIF":0.0,"publicationDate":"2020-02-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"77590035","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The efficacy of different doses of vitamin C in prevention and treatment of non-alcoholic fatty liver disease in mice 不同剂量维生素C对小鼠非酒精性脂肪性肝病的防治作用
Pub Date : 2020-02-15 DOI: 10.3760/CMA.J.ISSN.0254-1432.2020.02.010
Q. Zeng, Lili Zhao, Dengke Zhi, Kai Wang, Deling Kong, Jia Li
Objective To investigate the efficacy of different doses of vitamin C (VC) in prevention and treatment of non-alcoholic fatty liver disease (NAFLD) in mice. Methods C57BL/6 mice were fed with high-fat diet to establish NAFLD models. The experimental animals were divided into early prevention and later treatment groups. Both of these two experimental processes had five subgroups, including control, high-fat diet (HFD), low-dose vitamin C (LD-VC, 15 mg/kg per day), medium-dose vitamin C (MD-VC, 30 mg/kg per day) and high-dose vitamin C (HD-VC, 90 mg/kg per day) subgroup, with six mice in each subgroup. In the early prevention group, the mice were prophylactically received VC for 12 weeks. In the later treatment group, the mice were treated with different dose of VC for 12 weeks after fed with HFD for six weeks and confirmed NAFLD by liver pathology. The differences in body weight, perirenal adipose tissue mass and serum levels of alanine aminotransferase (ALT), aspartate aminotransferase (AST), total cholesterol (TC), and triacylglycerol (TG) were observed among different groups. The scores of hepatocyte steatosis, lobular inflammation and ballooning in liver histopathology of mice in each group were evaluated by non-alcoholic fatty liver disease activity score (NAS) scoring system. Tukey′s multiple comparison test and Kruskal-Wallis H test were performed for statistical analysis. Results In the early prevention group, the body weight, perirenal adipose tissue mass, TG level and the score of liver steatosis of LD-VC subgroup were all lower than those of HFD subgroup ((30.27±0.94) g vs. (32.18±1.35) g, (0.25±0.05) g vs. (0.32±0.02) g, (0.25±0.02) mmol/L vs. (0.30±0.03) mmol/L, 0 vs. 1.0(1.0)). The body weight, perirenal adipose tissue mass, blood glucose level, TG level and score of liver steatosis of MD-VC subgroup were all lower than those of HFD subgroup ( (29.72±0.58) g vs. (32.18±1.35) g, (0.24±0.05) g vs. (0.32±0.02) g, (6.93±0.59) mmol/L vs. (8.33±1.02) mmol/L, (0.24±0.04) mmol/L vs. (0.30±0.03) mmol/L, 0 vs. 1.0(1.0)); meanwhile, the blood glucose level and TG level of HD-VC subgroup were both lower than those of HFD subgroup ((6.72±0.59) mmol/L vs. (8.33±1.02) mmol/L, (0.23±0.04) mmol/L vs. (0.30±0.03) mmol/L), and the differences were statistically significant (all P<0.05). In the later treatment group, TG level of LD-VC subgroup was lower than that of HFD subgroup ((0.25±0.07) mmol/L vs. (0.37±0.06) mmol/L); the body weight, perirenal adipose tissue mass, blood glucose level, TG level and liver steatosis score of MD-VC subgroup were lower than those of HFD subgroup ((29.93±1.28) g vs. (33.24±2.45) g, (0.29±0.08) g vs. (0.53±0.14) g, (7.63±0.57) mmol/L vs. (9.13±1.52) mmol/L, (0.23±0.03) mmol/L vs. (0.37±0.06) mmol/L, 0.5(1.0) vs. 2.0(1.0)); the blood glucose level and TG level of HD-VC subgroup were both lower than those of HFD subgroup ((7.20±0.72) mmol/L vs. (9.13±1.52) mmol/L, (0.19±0.03) mmol/L vs. (0.37±0.06) mmol/L); ho
目的探讨不同剂量维生素C (VC)对小鼠非酒精性脂肪性肝病(NAFLD)的防治作用。方法采用高脂饲料喂养C57BL/6小鼠,建立NAFLD模型。实验动物分为早期预防组和后期治疗组。两个实验过程均分为5个亚组,即对照组、高脂饮食(HFD)、低剂量维生素C (LD-VC, 15 mg/kg / d)、中剂量维生素C (MD-VC, 30 mg/kg / d)和高剂量维生素C (HD-VC, 90 mg/kg / d)亚组,每个亚组6只小鼠。在早期预防组,小鼠预防性接受VC治疗12周。后处理组小鼠在HFD喂养6周后,再给予不同剂量的VC治疗12周,肝脏病理证实为NAFLD。观察各组大鼠体重、肾周脂肪组织质量及血清谷丙转氨酶(ALT)、天冬氨酸转氨酶(AST)、总胆固醇(TC)、甘油三酯(TG)水平的差异。采用非酒精性脂肪性肝病活动度评分(NAS)评分系统评价各组小鼠肝组织病理学中肝细胞脂肪变性、小叶炎症和肝球囊的评分。采用Tukey多重比较检验和Kruskal-Wallis H检验进行统计学分析。结果早期预防组LD-VC亚组体重、肾周脂肪组织质量、TG水平及肝脏脂肪变性评分均低于HFD亚组((30.27±0.94)g∶(32.18±1.35)g、(0.25±0.05)g∶(0.32±0.02)g、(0.25±0.02)mmol/L∶(0.30±0.03)mmol/L、0∶1.0(1.0))。MD-VC亚组体重、肾周脂肪组织质量、血糖水平、TG水平及肝脏脂肪变性评分均低于HFD亚组((29.72±0.58)g∶(32.18±1.35)g、(0.24±0.05)g∶(0.32±0.02)g、(6.93±0.59)mmol/L∶(8.33±1.02)mmol/L、(0.24±0.04)mmol/L∶(0.30±0.03)mmol/L、0∶1.0(1.0));同时,HD-VC亚组血糖水平、TG水平均低于HFD亚组((6.72±0.59)mmol/L∶(8.33±1.02)mmol/L、(0.23±0.04)mmol/L∶(0.30±0.03)mmol/L),差异均有统计学意义(P<0.05)。治疗后期,LD-VC亚组TG水平低于HFD亚组((0.25±0.07)mmol/L vs(0.37±0.06)mmol/L);MD-VC亚组的体重、肾周脂肪组织质量、血糖水平、TG水平、肝脏脂肪变性评分均低于HFD亚组((29.93±1.28)g∶(33.24±2.45)g、(0.29±0.08)g∶(0.53±0.14)g、(7.63±0.57)mmol/L∶(9.13±1.52)mmol/L、(0.23±0.03)mmol/L∶(0.37±0.06)mmol/L、0.5(1.0)∶2.0(1.0));HD-VC亚组血糖水平和TG水平均低于HFD亚组((7.20±0.72)mmol/L∶(9.13±1.52)mmol/L、(0.19±0.03)mmol/L∶(0.37±0.06)mmol/L);而HD-VC亚组的体重、肝质量、肾周脂肪组织质量、小叶炎症评分均高于HFD亚组((36.34±2.44)g∶(33.24±2.45)g、(1.18±0.07)g∶(1.06±0.09)g、(0.78±0.17)g∶(0.53±0.14)g、1.0(1.0)∶0(1.0)),差异均有统计学意义(P<0.05)。早期预防组LD-VC亚组的体重、肾周脂肪组织质量、肝脂肪变性、小叶炎症、球囊化评分均低于晚期治疗组LD-VC亚组((30.27±0.94)g∶(34.75±1.64)g、(0.25±0.05)g∶(0.61±0.14)g、0∶1.5(1.0)、0∶0.5(1.0)、0∶1.0(0));早期预防组HD-VC亚组体重、肝质量、肾周脂肪组织质量、ALT水平、AST水平及肝脂肪变性和小叶炎症评分均低于晚期治疗组HD-VC亚组((31.78±0.71)g∶(36.34±2.44)g、(1.01±0.02)g∶(1.18±0.07)g、(0.30±0.05)g∶(0.78±0.17)g、(8.83±0.98)U/L∶(12.75±2.05)U/L、(29.00±4.19)U/L∶(41.88±14.36)U/L、1.0(0)∶2.5(1.0)、0∶1.0(1.0))。差异均有统计学意义(P<0.05)。结论MD-VC可早期预防小鼠NAFLD的发生,并有利于小鼠NAFLD的后期治疗。然而,HD-VC在小鼠NAFLD的早期预防和后期治疗中具有潜在的风险。关键词:非酒精性脂肪肝;维生素C;预防;治疗;老鼠
{"title":"The efficacy of different doses of vitamin C in prevention and treatment of non-alcoholic fatty liver disease in mice","authors":"Q. Zeng, Lili Zhao, Dengke Zhi, Kai Wang, Deling Kong, Jia Li","doi":"10.3760/CMA.J.ISSN.0254-1432.2020.02.010","DOIUrl":"https://doi.org/10.3760/CMA.J.ISSN.0254-1432.2020.02.010","url":null,"abstract":"Objective \u0000To investigate the efficacy of different doses of vitamin C (VC) in prevention and treatment of non-alcoholic fatty liver disease (NAFLD) in mice. \u0000 \u0000 \u0000Methods \u0000C57BL/6 mice were fed with high-fat diet to establish NAFLD models. The experimental animals were divided into early prevention and later treatment groups. Both of these two experimental processes had five subgroups, including control, high-fat diet (HFD), low-dose vitamin C (LD-VC, 15 mg/kg per day), medium-dose vitamin C (MD-VC, 30 mg/kg per day) and high-dose vitamin C (HD-VC, 90 mg/kg per day) subgroup, with six mice in each subgroup. In the early prevention group, the mice were prophylactically received VC for 12 weeks. In the later treatment group, the mice were treated with different dose of VC for 12 weeks after fed with HFD for six weeks and confirmed NAFLD by liver pathology. The differences in body weight, perirenal adipose tissue mass and serum levels of alanine aminotransferase (ALT), aspartate aminotransferase (AST), total cholesterol (TC), and triacylglycerol (TG) were observed among different groups. The scores of hepatocyte steatosis, lobular inflammation and ballooning in liver histopathology of mice in each group were evaluated by non-alcoholic fatty liver disease activity score (NAS) scoring system. Tukey′s multiple comparison test and Kruskal-Wallis H test were performed for statistical analysis. \u0000 \u0000 \u0000Results \u0000In the early prevention group, the body weight, perirenal adipose tissue mass, TG level and the score of liver steatosis of LD-VC subgroup were all lower than those of HFD subgroup ((30.27±0.94) g vs. (32.18±1.35) g, (0.25±0.05) g vs. (0.32±0.02) g, (0.25±0.02) mmol/L vs. (0.30±0.03) mmol/L, 0 vs. 1.0(1.0)). The body weight, perirenal adipose tissue mass, blood glucose level, TG level and score of liver steatosis of MD-VC subgroup were all lower than those of HFD subgroup ( (29.72±0.58) g vs. (32.18±1.35) g, (0.24±0.05) g vs. (0.32±0.02) g, (6.93±0.59) mmol/L vs. (8.33±1.02) mmol/L, (0.24±0.04) mmol/L vs. (0.30±0.03) mmol/L, 0 vs. 1.0(1.0)); meanwhile, the blood glucose level and TG level of HD-VC subgroup were both lower than those of HFD subgroup ((6.72±0.59) mmol/L vs. (8.33±1.02) mmol/L, (0.23±0.04) mmol/L vs. (0.30±0.03) mmol/L), and the differences were statistically significant (all P<0.05). In the later treatment group, TG level of LD-VC subgroup was lower than that of HFD subgroup ((0.25±0.07) mmol/L vs. (0.37±0.06) mmol/L); the body weight, perirenal adipose tissue mass, blood glucose level, TG level and liver steatosis score of MD-VC subgroup were lower than those of HFD subgroup ((29.93±1.28) g vs. (33.24±2.45) g, (0.29±0.08) g vs. (0.53±0.14) g, (7.63±0.57) mmol/L vs. (9.13±1.52) mmol/L, (0.23±0.03) mmol/L vs. (0.37±0.06) mmol/L, 0.5(1.0) vs. 2.0(1.0)); the blood glucose level and TG level of HD-VC subgroup were both lower than those of HFD subgroup ((7.20±0.72) mmol/L vs. (9.13±1.52) mmol/L, (0.19±0.03) mmol/L vs. (0.37±0.06) mmol/L); ho","PeriodicalId":10009,"journal":{"name":"中华消化杂志","volume":"3 1","pages":"115-121"},"PeriodicalIF":0.0,"publicationDate":"2020-02-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"87533938","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Three cases of novel coronavirus pneumonia with viral nucleic acids still positive in stool after throat swab detection turned negative 新型冠状病毒肺炎3例,咽拭子检测阴性后粪便病毒核酸仍呈阳性
Pub Date : 2020-02-14 DOI: 10.3760/CMA.J.ISSN.0254-1432.2020.02.002
Zhiwei Yang, Ganwen Li, X. Dai, Guirong Liu, Gang Li
The novel coronavirus pneumonia (NCP) has spread from Wuhan to all parts of China since December 2019, and the prevention and control of NCP is a top priority for medical staff. Now report three cases of NCP patients, whose viral nucleic acids still positive in stool after throat swab detection turned negative. In view of the highly homologous and similar clinical manifestations between the 2019 novel coronavirus (2019-nCoV) and the severe acute respiratory syndrome(SARS) related coronaviruses, it is recommended to attach great importance to the detection of the viral nucleic acids in stool, with the reference of SARS prevention and control experience. In order to minimize the risks of gastrointestinal spread, the detection of 2019-nCoV nucleic acids in stool may be recommended as the reference standard of disisolation and discharge. Key words: Novel coronavirus pneumonia; Stool; Throat swab; Prevention and control
自2019年12月以来,新型冠状病毒肺炎(NCP)已从武汉蔓延到全国各地,防控新冠肺炎是医护人员的首要任务。现报告3例新型冠状病毒肺炎患者,经咽拭子检测呈阴性,粪便中病毒核酸仍呈阳性。鉴于2019新型冠状病毒(2019- ncov)与严重急性呼吸综合征(SARS)相关冠状病毒具有高度同源性和相似性的临床表现,建议高度重视粪便中病毒核酸的检测,参考SARS防控经验。为最大限度降低胃肠道传播风险,建议将粪便中新型冠状病毒核酸检测作为解除隔离和出院的参考标准。关键词:新型冠状病毒肺炎;凳子;咽喉拭子;预防和控制
{"title":"Three cases of novel coronavirus pneumonia with viral nucleic acids still positive in stool after throat swab detection turned negative","authors":"Zhiwei Yang, Ganwen Li, X. Dai, Guirong Liu, Gang Li","doi":"10.3760/CMA.J.ISSN.0254-1432.2020.02.002","DOIUrl":"https://doi.org/10.3760/CMA.J.ISSN.0254-1432.2020.02.002","url":null,"abstract":"The novel coronavirus pneumonia (NCP) has spread from Wuhan to all parts of China since December 2019, and the prevention and control of NCP is a top priority for medical staff. Now report three cases of NCP patients, whose viral nucleic acids still positive in stool after throat swab detection turned negative. In view of the highly homologous and similar clinical manifestations between the 2019 novel coronavirus (2019-nCoV) and the severe acute respiratory syndrome(SARS) related coronaviruses, it is recommended to attach great importance to the detection of the viral nucleic acids in stool, with the reference of SARS prevention and control experience. In order to minimize the risks of gastrointestinal spread, the detection of 2019-nCoV nucleic acids in stool may be recommended as the reference standard of disisolation and discharge. \u0000 \u0000Key words: \u0000Novel coronavirus pneumonia; Stool; Throat swab; Prevention and control","PeriodicalId":10009,"journal":{"name":"中华消化杂志","volume":"39 1","pages":"77-79"},"PeriodicalIF":0.0,"publicationDate":"2020-02-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"73277053","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 31
Prognostic Nomogram model for the efficacy of endoscopic treatment in gastric varices caused by liver cirrhosis 内镜治疗肝硬化胃底静脉曲张疗效的预后Nomogram模型
Pub Date : 2020-01-15 DOI: 10.3760/CMA.J.ISSN.0254-1432.2020.01.005
Xiaoqing Zeng, Yuzhen Zeng, Ji Zhou, Jie Chen, T. Luo, Wen Zhang, Pengju Xu, Jianjun Luo, Zhiping Yan, Shi-yao Chen
Objective To predict the efficacy of endoscopic tissue adhesives in the treatment of gastric varices in patients with liver cirrhosis by Nomogram model. Methods From August 2014 to September 2017, 158 patients with liver cirrhosis caused esophagogastric variceal bleeding and received endoscopic tissue adhesives treatment at Zhongshan Hospital, Fudan University were collected. All patients were followed for 12 months. The primary outcome was rebleeding. The factors of rebleeding after endoscopic treatment of esophagogastric varices were analyzed. Nomogram prognostic model was developed and compared with Child-Pugh grading, computed tomography angiography (CTA) and hepatic venous pressure gradient (HVPG) in prognostic accuracy in rebleeding after endoscopic treatment in liver cirrhosis caused esophagogastric varices. Univariate and multivaricate Cox regression analysis, Kaplan-Meier curve and log-rank test were performed for statistical analysis. Results During the follow-up, rebleading occurred in 18 cases (11.4%), 37 cases (23.4%) and 49 cases (31.0%) at 2, 6, and 12 months after endoscopic treatment. The results of univariate Cox regression analysis showed the risk factors of rebleeding after endoscopic treatment of gastric varices included gender, alcoholic liver cirrhosis, diabetes mellitus, Child-Pugh grade (Grade A vs. B or C), extraluminal vessels on CTA (presence vs. absence) HVPG ( 3 points), injection volume of tissue adhesive (≤ 3 mL vs. > 3 mL) (hazard ratio (HR)=0.575, 2.018, 1.562, 3.433, 2.945, 1.859, 2.743, 0.324, 1.840, 1.477, and 1.716; 95% confidence interval (CI) 0.305 to 1.084, 0.902 to 4.514, 1.753 to 6.724, 1.663 to 5.217, 1.012 to 3.415, 0.852 to 8.830, 0.079 to 1.335, 1.012 to 3.317, 0.839 to 2.602, and 0.935 to 3.152; all P<0.2). The results of multivariate Cox regression analysis indicated that Child-Pugh grade, extraluminal vessels by CTA, and HVPG (HR = 2.095, 95% CI 1.099 to 3.995, P = 0.025) were all independent risk factors of rebleeding after endoscopic treatment of gastric varices (HR=2.665, 2.886, and 2.095; 95% CI 1.339 to 5.300, 1.580 to 5.271, and 1.099 to 3.995; all P<0.05). Kaplan-Meier curves showed that Child-Pugh grade (Grade A vs. B or C), extraluminal vessels on CTA (presence or absent) and HVPG (<16 mmHg vs. ≥16 mmHg) could effectively predict cumulative non-rebleeding rate in one year after endoscopic treatment of gastric varices, and the differences were statistically significant (all P<0.05). Receiver operataring characteristic curve analysis demonstrated that the predictive value of the model combined with Child-Pugh grade, extraluminal vessels on CTA and HVPG was higher than that of Child-Pugh grade and HVPG (AUC=0.746, 0.673 and 0.585; 95% CI 0.662 to 0.829, 0.583 to 0.762, and 0.486 to 0.683; P<0.01, P=0.001 and P=0.089, respectively). Patients were divided into low, medium, and high-risk groups according to the 25th and 75th percentiles of the Nomogram score. The results showed tha
目的应用Nomogram模型预测内镜下组织粘接剂治疗肝硬化胃静脉曲张的疗效。方法收集2014年8月至2017年9月复旦大学附属中山医院收治的肝硬化食管胃静脉曲张出血并经内镜组织粘接剂治疗的患者158例。所有患者随访12个月。主要结局是再出血。分析食管胃静脉曲张内镜治疗后再出血的因素。建立Nomogram预后模型,并与Child-Pugh分级、ct血管造影(CTA)和肝静脉压梯度(HVPG)对肝硬化食管胃底静脉曲张内镜治疗后再出血的预测准确性进行比较。采用单变量和多变量Cox回归分析、Kaplan-Meier曲线和log-rank检验进行统计分析。结果随访中,内镜治疗后2个月、6个月和12个月分别有18例(11.4%)、37例(23.4%)和49例(31.0%)出现复发。单因素Cox回归分析结果显示,胃底静脉曲张内镜治疗后再出血的危险因素包括性别、酒精性肝硬化、糖尿病、Child-Pugh分级(A级vs B级或C级)、CTA上腔外血管(存在vs不存在)HVPG(3分)、组织粘胶剂注射量(≤3 mL vs bb0 3 mL)(风险比(HR)=0.575、2.018、1.562、3.433、2.945、1.859、2.743、0.324、1.840、1.477、1.716;95%置信区间(CI) 0.305 ~ 1.084、0.902 ~ 4.514、1.753 ~ 6.724、1.663 ~ 5.217、1.012 ~ 3.415、0.852 ~ 8.830、0.079 ~ 1.335、1.012 ~ 3.317、0.839 ~ 2.602、0.935 ~ 3.152;所有P < 0.2)。多因素Cox回归分析结果显示,Child-Pugh分级、CTA腔外血管、HVPG (HR= 2.095, 95% CI 1.099 ~ 3.995, P = 0.025)均为胃底静脉曲张内镜治疗后再出血的独立危险因素(HR=2.665、2.886、2.095;95% CI 1.339 ~ 5.300, 1.580 ~ 5.271, 1.099 ~ 3.995;所有P < 0.05)。Kaplan-Meier曲线显示Child-Pugh分级(A级vs B级或C级)、CTA上的腔外血管(有无)和HVPG (<16 mmHg vs≥16 mmHg)可有效预测胃底静脉曲张内镜治疗后1年内的累计不再出血率,差异均有统计学意义(P<0.05)。受试者工作特征曲线分析表明,结合Child-Pugh分级、腔外血管对CTA和HVPG的预测价值高于Child-Pugh分级和HVPG (AUC=0.746、0.673和0.585);95% CI为0.662 ~ 0.829,0.583 ~ 0.762,0.486 ~ 0.683;P<0.01, P=0.001, P=0.089)。根据Nomogram评分第25、75百分位分为低、中、高危组。结果显示Nomogram模型能有效区分胃底静脉曲张内镜治疗后再出血高危人群,差异有统计学意义(P <0.01)。结论CTA、HVPG、Child-Pugh分级是胃底静脉曲张内镜治疗后再出血的独立预后评价指标。基于这三个预后因素的Nomogram预测模型的预测精度可能优于Child-Pugh分级和HVPG。关键词:肝硬化;预后;列线图;胃静脉曲张;内镜下治疗
{"title":"Prognostic Nomogram model for the efficacy of endoscopic treatment in gastric varices caused by liver cirrhosis","authors":"Xiaoqing Zeng, Yuzhen Zeng, Ji Zhou, Jie Chen, T. Luo, Wen Zhang, Pengju Xu, Jianjun Luo, Zhiping Yan, Shi-yao Chen","doi":"10.3760/CMA.J.ISSN.0254-1432.2020.01.005","DOIUrl":"https://doi.org/10.3760/CMA.J.ISSN.0254-1432.2020.01.005","url":null,"abstract":"Objective \u0000To predict the efficacy of endoscopic tissue adhesives in the treatment of gastric varices in patients with liver cirrhosis by Nomogram model. \u0000 \u0000 \u0000Methods \u0000From August 2014 to September 2017, 158 patients with liver cirrhosis caused esophagogastric variceal bleeding and received endoscopic tissue adhesives treatment at Zhongshan Hospital, Fudan University were collected. All patients were followed for 12 months. The primary outcome was rebleeding. The factors of rebleeding after endoscopic treatment of esophagogastric varices were analyzed. Nomogram prognostic model was developed and compared with Child-Pugh grading, computed tomography angiography (CTA) and hepatic venous pressure gradient (HVPG) in prognostic accuracy in rebleeding after endoscopic treatment in liver cirrhosis caused esophagogastric varices. Univariate and multivaricate Cox regression analysis, Kaplan-Meier curve and log-rank test were performed for statistical analysis. \u0000 \u0000 \u0000Results \u0000During the follow-up, rebleading occurred in 18 cases (11.4%), 37 cases (23.4%) and 49 cases (31.0%) at 2, 6, and 12 months after endoscopic treatment. The results of univariate Cox regression analysis showed the risk factors of rebleeding after endoscopic treatment of gastric varices included gender, alcoholic liver cirrhosis, diabetes mellitus, Child-Pugh grade (Grade A vs. B or C), extraluminal vessels on CTA (presence vs. absence) HVPG ( 3 points), injection volume of tissue adhesive (≤ 3 mL vs. > 3 mL) (hazard ratio (HR)=0.575, 2.018, 1.562, 3.433, 2.945, 1.859, 2.743, 0.324, 1.840, 1.477, and 1.716; 95% confidence interval (CI) 0.305 to 1.084, 0.902 to 4.514, 1.753 to 6.724, 1.663 to 5.217, 1.012 to 3.415, 0.852 to 8.830, 0.079 to 1.335, 1.012 to 3.317, 0.839 to 2.602, and 0.935 to 3.152; all P<0.2). The results of multivariate Cox regression analysis indicated that Child-Pugh grade, extraluminal vessels by CTA, and HVPG (HR = 2.095, 95% CI 1.099 to 3.995, P = 0.025) were all independent risk factors of rebleeding after endoscopic treatment of gastric varices (HR=2.665, 2.886, and 2.095; 95% CI 1.339 to 5.300, 1.580 to 5.271, and 1.099 to 3.995; all P<0.05). Kaplan-Meier curves showed that Child-Pugh grade (Grade A vs. B or C), extraluminal vessels on CTA (presence or absent) and HVPG (<16 mmHg vs. ≥16 mmHg) could effectively predict cumulative non-rebleeding rate in one year after endoscopic treatment of gastric varices, and the differences were statistically significant (all P<0.05). Receiver operataring characteristic curve analysis demonstrated that the predictive value of the model combined with Child-Pugh grade, extraluminal vessels on CTA and HVPG was higher than that of Child-Pugh grade and HVPG (AUC=0.746, 0.673 and 0.585; 95% CI 0.662 to 0.829, 0.583 to 0.762, and 0.486 to 0.683; P<0.01, P=0.001 and P=0.089, respectively). Patients were divided into low, medium, and high-risk groups according to the 25th and 75th percentiles of the Nomogram score. The results showed tha","PeriodicalId":10009,"journal":{"name":"中华消化杂志","volume":"21 1","pages":"23-29"},"PeriodicalIF":0.0,"publicationDate":"2020-01-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"84864602","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Role of intestinal barrier in the pathogenesis of autoimmune hepatitis 肠道屏障在自身免疫性肝炎发病机制中的作用
Pub Date : 2020-01-15 DOI: 10.3760/CMA.J.ISSN.0254-1432.2020.01.003
Hongxia Zhang, W. Cai, Yanni Li, Simin Zhou, Lu Zhou
Objective To observe and analyze the role of intestinal barrier in the pathognesis of autoimmune hepatitis (AIH), to explain the pathogenesis of AIH and to explore the intestinal based new treatment strategies. Methods A total of 14 AIH patients from January to December 2017 at Tianjin Medical University General Hospital (six patients without liver cirrhosis, and eight patients with liver cirrhosis) and 10 healthy controls were enrolled. The serum levels of D-lactic acid (D-Lac) and diamine oxidase (DAO) were detected by enzyme-linked immunosorbent assay. Real time fluorescence quantitative polymerase chain reaction was used to detect the relative expression levels of connexin (zonula occluden-1 (ZO-1), occludin), cytokines (interleukin(IL)-2, interferon(IFN)-γ, IL-4, IL-10) and Toll-like receptor 4 (TLR4) in terminal ileal tissues of each group. The relative expression of secretory immunoglobulin A (sIgA) in the terminal ileum was determined by Western blotting. Thirty BALB/c mice were selected and divided into blank control group, dextran sulfate sodium (DSS) group, concanavalin A (ConA) group, DSS+ ConA group, and DSS+ bacterium+ ConA group, with six mice in each group. The relative expression levels of ZO-1, occludin in mouse colonic tissues, serum alanine aminotransferase (ALT) and aspartate aminotransferase (AST) levels, and inflammatory activity degree of liver tissues (Knodell score) of each group were measured. T-test and one-way analysis of variance were performed for statistical analysis. Results The serum D-Lac and DAO levels of AIH with liver cirrhosis group and AIH without liver cirrhosis group were both higher than those of healthy control group ((1 768.2±147.1) μg/L, (436.2±197.0) μg/L vs. (100.2±10.9) μg/L, and (11.5±2.5) U/L, (5.4±0.9) U/mL vs. (3.5±0.9) U/mL), and the levels of D-Lac and DAO of AIH with liver cirrhosis group were the highest; and the differences were statistically significant (t=5.512, 36.010, 4.088 and 9.443, F=396.958 and 46.640, all P<0.01). The relative expression levels of ZO-1 and occludin in the terminal ileal mucosa of AIH with liver cirrhosis group were lower than those of healthy control group (0.20±0.14 vs. 1.67±0.51, 0.12±0.09 vs. 0.90±0.21), and the relative expression of ZO-1 in AIH without liver cirrhosis group was lower than that in healthy control group (0.99±0.37 vs. 1.67±0.51); and the differences were statistically significant (t=8.641, 7.407 and 2.295, all P<0.05). The relative expression levels of IL-2 and IFN-γ in terminal ileal tissues of AIH with liver cirrhosis group were higher than those of healthy control group (1.11±0.43 vs. 0.24 ±0.16, and 3.50 ± 1.90 vs. 0.32±0.30), however the relative expression of sIgA in terminal ileal tissues was lower than that of healthy control group (0.506±0.024 vs. 1.081±0.102); and the differences were statistically significant (t=4.679, 3.981 and 5.493, all P<0.05). While the relative expression levels of IL-10 in AIH with liver cirrhosis
目的观察和分析肠道屏障在自身免疫性肝炎(AIH)发病机制中的作用,探讨以肠道为基础的治疗新策略。方法选取2017年1 - 12月天津医科大学总医院AIH患者14例(无肝硬化患者6例,肝硬化患者8例)和健康对照10例。采用酶联免疫吸附法检测血清d -乳酸(D-Lac)和二胺氧化酶(DAO)水平。采用实时荧光定量聚合酶链反应检测各组回肠末端组织中连接蛋白(zonula occluden-1 (ZO-1)、occludin)、细胞因子(interleukin(IL)-2、干扰素(IFN)-γ、IL-4、IL-10)和toll样受体4 (TLR4)的相对表达水平。Western blotting检测回肠末端分泌性免疫球蛋白A (sIgA)的相对表达。选取BALB/c小鼠30只,分为空白对照组、葡聚糖硫酸钠(DSS)组、魔芋蛋白A (ConA)组、DSS+ ConA组和DSS+细菌+ ConA组,每组6只。测定各组小鼠结肠组织中ZO-1、occludin的相对表达水平、血清谷丙转氨酶(ALT)和天冬氨酸转氨酶(AST)水平及肝脏组织炎症活动度(Knodell评分)。采用t检验和单因素方差分析进行统计分析。结果AIH合并肝硬化组和AIH无肝硬化组血清D-Lac和DAO水平均高于健康对照组((1 768.2±147.1)μg/L、(436.2±197.0)μg/L比(100.2±10.9)μg/L、(11.5±2.5)U/L、(5.4±0.9)U/mL比(3.5±0.9)U/mL),且AIH合并肝硬化组D-Lac和DAO水平最高;差异有统计学意义(t=5.512、36.010、4.088、9.443,F=396.958、46.640,P均<0.01)。AIH伴肝硬化组回肠末端黏膜ZO-1、occludin的相对表达量低于健康对照组(0.20±0.14∶1.67±0.51、0.12±0.09∶0.90±0.21),无肝硬化AIH组ZO-1的相对表达量低于健康对照组(0.99±0.37∶1.67±0.51);差异有统计学意义(t=8.641、7.407、2.295,P均<0.05)。AIH合并肝硬化组回肠末组织IL-2、IFN-γ相对表达量高于健康对照组(1.11±0.43比0.24±0.16,3.50±1.90比0.32±0.30),sIgA相对表达量低于健康对照组(0.506±0.024比1.081±0.102);差异有统计学意义(t=4.679、3.981、5.493,P均<0.05)。AIH合并肝硬化组和AIH无肝硬化组IL-10相对表达量均低于健康对照组(0.30±0.20,0.42±0.24 vs 0.84±0.23),两组回肠黏膜TLR4相对表达量均高于健康对照组(8.74±5.13,6.74±3.65 vs 0.89±0.70);差异均有统计学意义(t=3.095、4.816、3.856、3.685,P均<0.05)。DSS+ ConA组ZO-1和occludin的相对表达量低于ConA组(0.14±0.08 vs 0.98±0.13,0.09±0.02 vs 0.98±0.16),而血清ALT、AST水平和Knodell评分均高于ConA组((5 496.67±618.83)U/L vs(3 325.00±1 030.06)U/L,(8 825.00±1 165.35)U/L vs(5 433.33±1 691.14)U/L, 18.00±2.00 vs 9.33±3.01);差异均有统计学意义(t=13.480、13.520、4.227、4.045、-2.892,P均<0.05)。DSS+细菌+ ConA组ZO-1和occludin的相对表达量高于DSS+ ConA组(0.46±0.08 vs 0.14±0.08,0.53±0.15 vs 0.09±0.02),血清ALT和AST水平低于DSS+ ConA组((4 343.33±252.16)U/L vs(5 496.67±618.83)U/L,(6 123.33±1 086.60)U/L vs(8 825.00±1 165.35)U/L);差异有统计学意义(t=6.928、7.122、4.228、4.153,P均<0.01)。结论AIH患者肠通透性增高,肠屏障受损,肝硬化患者较无肝硬化患者更为严重。肠屏障损伤可加重cona诱导的免疫介导肝损伤。而肠屏障的保护和修复可以减轻ConA诱导的免疫介导的肝损伤。关键词:肝炎;自身免疫;伴刀豆球蛋白A;肠黏膜屏障;葡聚糖硫酸钠;双歧杆菌属
{"title":"Role of intestinal barrier in the pathogenesis of autoimmune hepatitis","authors":"Hongxia Zhang, W. Cai, Yanni Li, Simin Zhou, Lu Zhou","doi":"10.3760/CMA.J.ISSN.0254-1432.2020.01.003","DOIUrl":"https://doi.org/10.3760/CMA.J.ISSN.0254-1432.2020.01.003","url":null,"abstract":"Objective \u0000To observe and analyze the role of intestinal barrier in the pathognesis of autoimmune hepatitis (AIH), to explain the pathogenesis of AIH and to explore the intestinal based new treatment strategies. \u0000 \u0000 \u0000Methods \u0000A total of 14 AIH patients from January to December 2017 at Tianjin Medical University General Hospital (six patients without liver cirrhosis, and eight patients with liver cirrhosis) and 10 healthy controls were enrolled. The serum levels of D-lactic acid (D-Lac) and diamine oxidase (DAO) were detected by enzyme-linked immunosorbent assay. Real time fluorescence quantitative polymerase chain reaction was used to detect the relative expression levels of connexin (zonula occluden-1 (ZO-1), occludin), cytokines (interleukin(IL)-2, interferon(IFN)-γ, IL-4, IL-10) and Toll-like receptor 4 (TLR4) in terminal ileal tissues of each group. The relative expression of secretory immunoglobulin A (sIgA) in the terminal ileum was determined by Western blotting. Thirty BALB/c mice were selected and divided into blank control group, dextran sulfate sodium (DSS) group, concanavalin A (ConA) group, DSS+ ConA group, and DSS+ bacterium+ ConA group, with six mice in each group. The relative expression levels of ZO-1, occludin in mouse colonic tissues, serum alanine aminotransferase (ALT) and aspartate aminotransferase (AST) levels, and inflammatory activity degree of liver tissues (Knodell score) of each group were measured. T-test and one-way analysis of variance were performed for statistical analysis. \u0000 \u0000 \u0000Results \u0000The serum D-Lac and DAO levels of AIH with liver cirrhosis group and AIH without liver cirrhosis group were both higher than those of healthy control group ((1 768.2±147.1) μg/L, (436.2±197.0) μg/L vs. (100.2±10.9) μg/L, and (11.5±2.5) U/L, (5.4±0.9) U/mL vs. (3.5±0.9) U/mL), and the levels of D-Lac and DAO of AIH with liver cirrhosis group were the highest; and the differences were statistically significant (t=5.512, 36.010, 4.088 and 9.443, F=396.958 and 46.640, all P<0.01). The relative expression levels of ZO-1 and occludin in the terminal ileal mucosa of AIH with liver cirrhosis group were lower than those of healthy control group (0.20±0.14 vs. 1.67±0.51, 0.12±0.09 vs. 0.90±0.21), and the relative expression of ZO-1 in AIH without liver cirrhosis group was lower than that in healthy control group (0.99±0.37 vs. 1.67±0.51); and the differences were statistically significant (t=8.641, 7.407 and 2.295, all P<0.05). The relative expression levels of IL-2 and IFN-γ in terminal ileal tissues of AIH with liver cirrhosis group were higher than those of healthy control group (1.11±0.43 vs. 0.24 ±0.16, and 3.50 ± 1.90 vs. 0.32±0.30), however the relative expression of sIgA in terminal ileal tissues was lower than that of healthy control group (0.506±0.024 vs. 1.081±0.102); and the differences were statistically significant (t=4.679, 3.981 and 5.493, all P<0.05). While the relative expression levels of IL-10 in AIH with liver cirrhosis","PeriodicalId":10009,"journal":{"name":"中华消化杂志","volume":"10 1","pages":"9-15"},"PeriodicalIF":0.0,"publicationDate":"2020-01-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"87966846","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Feasibility of expanded indication for endoscopic submucosal dissection in undifferentiated early gastric cancer 扩大内镜下粘膜下剥离治疗未分化早期胃癌适应症的可行性
Pub Date : 2020-01-15 DOI: 10.3760/CMA.J.ISSN.0254-1432.2020.01.006
Yu-Ning Chu, Tao Mao, Xue Jing, Yanan Yu, Xueli Ding, Xiaoyu Li
Objective To evaluate the feasibility of expanded indication for endoscopic submucosal dissection (ESD) in undifferentiated early gastric cancer, to investigate the risk factors of lymph node metastasis (LNM), so as to provide the theoretical evidence for the choice of treatment. Methods From June 2007 to December 2018, at the Affiliated Hospital of Qingdao University, the clinical and pathological data of 807 patients with undifferentiated early gastric cancer and undergoing gastrectomy plus lymphadenectomy were retrospectively analyzed. Chi-square test was performed to analyze the correlation between clinicopathologic characteristics of early gastric cancer and LNM. Multivariate logistic regression model was used to analyze the independent risk factor of LNM. Results LNM was found in 17.2% (139/807) patients with undifferentiated early gastric cancer. And no LNM was detected in 110 patients who met the expanded indication of ESD. The results of univariate analysis indicated that LNM was significantly associated with increased carcinoembryonic antigen (CEA), tumour size, gross type, ulcer, invasion depth, lymphovascular invasion and perineural invasion (χ2=4.500, 13.332, 16.611, 6.083, 51.064, 0.564 and 17.006, all P 500 μm ; OR=3.014, 95%CI 1.753 to 5.181, P<0.01) were independent risk factors of LNM in early gastric cancer. Conclusions The expanded ESD indication of undifferentiated early gastric cancer is applicable for endoscopic treatment considering the low risk of LNM. In early undifferentiated gastric cancer, maximum diameter of tumor over 20 mm, lymphovascular invasion, submucosal superficial and deep invasion are the independent risk factors of LNM. Key words: Endoscopic submucosal dissection; Risk factor; Undifferentiated early gastric cancer; Expanded indication; Lymph node metastasis
目的探讨未分化早期胃癌扩大内镜黏膜下剥离(ESD)适应症的可行性,探讨淋巴结转移(LNM)的危险因素,为治疗方案的选择提供理论依据。方法回顾性分析2007年6月至2018年12月青岛大学附属医院行胃切除术加淋巴结切除术的未分化早期胃癌患者807例的临床及病理资料。采用卡方检验分析早期胃癌的临床病理特征与LNM的相关性。采用多因素logistic回归模型分析LNM的独立危险因素。结果17.2%(139/807)未分化早期胃癌患者中有LNM。符合ESD扩展指征的110例患者未检出LNM。单因素分析结果显示,LNM与癌胚抗原(CEA)、肿瘤大小、大体类型、溃疡、浸润深度、淋巴血管浸润和神经周围浸润升高有显著相关性(χ2=4.500、13.332、16.611、6.083、51.064、0.564和17.006,P均为500 μm;OR=3.014, 95%CI 1.753 ~ 5.181, P<0.01)是早期胃癌LNM的独立危险因素。结论未分化早期胃癌扩大ESD指征适用于内镜下治疗,且LNM发生风险低。在早期未分化胃癌中,肿瘤最大直径大于20mm、淋巴血管浸润、粘膜下浅、深部浸润是LNM的独立危险因素。关键词:内镜下粘膜下剥离;风险因素;未分化早期胃癌;扩大迹象;淋巴结转移
{"title":"Feasibility of expanded indication for endoscopic submucosal dissection in undifferentiated early gastric cancer","authors":"Yu-Ning Chu, Tao Mao, Xue Jing, Yanan Yu, Xueli Ding, Xiaoyu Li","doi":"10.3760/CMA.J.ISSN.0254-1432.2020.01.006","DOIUrl":"https://doi.org/10.3760/CMA.J.ISSN.0254-1432.2020.01.006","url":null,"abstract":"Objective \u0000To evaluate the feasibility of expanded indication for endoscopic submucosal dissection (ESD) in undifferentiated early gastric cancer, to investigate the risk factors of lymph node metastasis (LNM), so as to provide the theoretical evidence for the choice of treatment. \u0000 \u0000 \u0000Methods \u0000From June 2007 to December 2018, at the Affiliated Hospital of Qingdao University, the clinical and pathological data of 807 patients with undifferentiated early gastric cancer and undergoing gastrectomy plus lymphadenectomy were retrospectively analyzed. Chi-square test was performed to analyze the correlation between clinicopathologic characteristics of early gastric cancer and LNM. Multivariate logistic regression model was used to analyze the independent risk factor of LNM. \u0000 \u0000 \u0000Results \u0000LNM was found in 17.2% (139/807) patients with undifferentiated early gastric cancer. And no LNM was detected in 110 patients who met the expanded indication of ESD. The results of univariate analysis indicated that LNM was significantly associated with increased carcinoembryonic antigen (CEA), tumour size, gross type, ulcer, invasion depth, lymphovascular invasion and perineural invasion (χ2=4.500, 13.332, 16.611, 6.083, 51.064, 0.564 and 17.006, all P 500 μm ; OR=3.014, 95%CI 1.753 to 5.181, P<0.01) were independent risk factors of LNM in early gastric cancer. \u0000 \u0000 \u0000Conclusions \u0000The expanded ESD indication of undifferentiated early gastric cancer is applicable for endoscopic treatment considering the low risk of LNM. In early undifferentiated gastric cancer, maximum diameter of tumor over 20 mm, lymphovascular invasion, submucosal superficial and deep invasion are the independent risk factors of LNM. \u0000 \u0000 \u0000Key words: \u0000Endoscopic submucosal dissection; Risk factor; Undifferentiated early gastric cancer; Expanded indication; Lymph node metastasis","PeriodicalId":10009,"journal":{"name":"中华消化杂志","volume":"15 1","pages":"30-35"},"PeriodicalIF":0.0,"publicationDate":"2020-01-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"90306094","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Primary study on clinical applications of second generation colon capsule endoscopy 第二代结肠胶囊内镜临床应用的初步研究
Pub Date : 2020-01-15 DOI: 10.3760/CMA.J.ISSN.0254-1432.2020.01.007
Jingjing Zhang, Lan Li, Huajing Su, Youming Li
Objective To explore the clinical applications of second generation colon capsule endoscopy (CCE-2). Methods From July 2017 to December 2018, at the First Affiliated Hospital, College of Medicine, Zhejiang University, 40 outpatients and hospitalized patients who underwent CCE-2 examination were enrolled. The examination results were analyzed by an expert gastroenterologist with rich experience in small intestinal and colon capsule endoscopy. The stomach, small bowel and colon transit time, the score of colon cleansing quality, the completion rate of colon capsule examination, lesion detection and adverse effects were observed. Chi-square test and Student′t test were used for statistical analysis. Results The whole gastrointestinal tract examination was completed during the capsule running time in 65.0% (26/40) of the patients. The average stomach transit time was (0.92±0.74) h, the small bowel transit time was (3.93±1.51) h and the colon transit time was (4.89±0.61) h. The capsule running time of patients who completed the whole gastrointestinal tract examination was shorter than that of patients who did not complete the whole gastrointestinal tract examination ((9.44 ± 3.53) h vs. (15.47±2.09) h), and the difference was statistically significant (t=6.79, P 0.05). A total of 33 (82.5%) patients had gastrointestinal lesions detected by colon capsule, including three cases of esophageal lesions (inflammation and mass), 21 cases of gastric lesions (chronic gastritis, mucosal protrusion, polyp and ulcer), nine cases of small bowel lesions (polyp, ulcer and vascular malformation) and 19 cases of colonic lesions (diverticulum, polyp, rectitis, mucosal erosion, ulcer and vascular malformation, internal hemorrhoids). Among them, there were 11 patients with two or more lesions. No adverse events occurred during the examination and all the capsules were excreted within 48 hours. Conclusion CCE-2 with high safety and good tolerance can be used for whole gastrointestinal tract examination. Key words: Second generation colon capsule endoscopy; Gastrointestinal examination; Colon cleansing quality; Safety
目的探讨第二代结肠胶囊内镜(CCE-2)的临床应用。方法选取2017年7月至2018年12月在浙江大学医学院第一附属医院行CCE-2检查的门诊和住院患者40例。检查结果由具有丰富小肠和结肠胶囊内镜经验的胃肠病学专家进行分析。观察两组患者的胃、小肠、结肠转运时间、结肠清洁质量评分、结肠胶囊检查完成率、病变检出率及不良反应。采用卡方检验和Student’t检验进行统计分析。结果65.0%(26/40)患者在胶囊运行时间内完成了全胃肠道检查。胃平均通过时间为(0.92±0.74)h,小肠平均通过时间为(3.93±1.51)h,结肠平均通过时间为(4.89±0.61)h。完成全胃肠道检查的患者胶囊运行时间短于未完成全胃肠道检查的患者((9.44±3.53)h∶(15.47±2.09)h),差异有统计学意义(t=6.79, P 0.05)。结肠胶囊检出胃肠道病变33例(82.5%),其中食管病变(炎症、肿块)3例,胃病变(慢性胃炎、粘膜突出、息肉、溃疡)21例,小肠病变(息肉、溃疡、血管畸形)9例,结肠病变(憩室、息肉、直肠炎、粘膜糜烂、溃疡、血管畸形、内痔)19例。其中两处及以上病变11例。检查过程中未发生不良反应,所有胶囊均在48小时内排出。结论CCE-2安全性高,耐受性好,可用于全胃肠道检查。关键词:第二代结肠胶囊内镜;胃肠检查;结肠清洁品质;安全
{"title":"Primary study on clinical applications of second generation colon capsule endoscopy","authors":"Jingjing Zhang, Lan Li, Huajing Su, Youming Li","doi":"10.3760/CMA.J.ISSN.0254-1432.2020.01.007","DOIUrl":"https://doi.org/10.3760/CMA.J.ISSN.0254-1432.2020.01.007","url":null,"abstract":"Objective \u0000To explore the clinical applications of second generation colon capsule endoscopy (CCE-2). \u0000 \u0000 \u0000Methods \u0000From July 2017 to December 2018, at the First Affiliated Hospital, College of Medicine, Zhejiang University, 40 outpatients and hospitalized patients who underwent CCE-2 examination were enrolled. The examination results were analyzed by an expert gastroenterologist with rich experience in small intestinal and colon capsule endoscopy. The stomach, small bowel and colon transit time, the score of colon cleansing quality, the completion rate of colon capsule examination, lesion detection and adverse effects were observed. Chi-square test and Student′t test were used for statistical analysis. \u0000 \u0000 \u0000Results \u0000The whole gastrointestinal tract examination was completed during the capsule running time in 65.0% (26/40) of the patients. The average stomach transit time was (0.92±0.74) h, the small bowel transit time was (3.93±1.51) h and the colon transit time was (4.89±0.61) h. The capsule running time of patients who completed the whole gastrointestinal tract examination was shorter than that of patients who did not complete the whole gastrointestinal tract examination ((9.44 ± 3.53) h vs. (15.47±2.09) h), and the difference was statistically significant (t=6.79, P 0.05). A total of 33 (82.5%) patients had gastrointestinal lesions detected by colon capsule, including three cases of esophageal lesions (inflammation and mass), 21 cases of gastric lesions (chronic gastritis, mucosal protrusion, polyp and ulcer), nine cases of small bowel lesions (polyp, ulcer and vascular malformation) and 19 cases of colonic lesions (diverticulum, polyp, rectitis, mucosal erosion, ulcer and vascular malformation, internal hemorrhoids). Among them, there were 11 patients with two or more lesions. No adverse events occurred during the examination and all the capsules were excreted within 48 hours. \u0000 \u0000 \u0000Conclusion \u0000CCE-2 with high safety and good tolerance can be used for whole gastrointestinal tract examination. \u0000 \u0000 \u0000Key words: \u0000Second generation colon capsule endoscopy; Gastrointestinal examination; Colon cleansing quality; Safety","PeriodicalId":10009,"journal":{"name":"中华消化杂志","volume":"110 1","pages":"36-39"},"PeriodicalIF":0.0,"publicationDate":"2020-01-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"75626641","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Correlation between anti-mitochondrial antibodies and clinical serological and cirrhotic markers of primary biliary cholangitis 抗线粒体抗体与原发性胆管炎临床血清学及肝硬化标志物的相关性
Pub Date : 2020-01-15 DOI: 10.3760/CMA.J.ISSN.0254-1432.2020.01.004
R. Jin, Xiaoxiao Wang, Lihua Wang, Hui Ma, Ji-lian Fang, Hao Wang, H. Rao, Lai Wei, B. Feng
Objective To explore the correlation between the level of anti-mitochondrial antibody (AMA) and clinical indicators of first visited primary biliary cholangitis (PBC) patients with positive AMA. Methods From January 2013 to December 2016, the clinical data of 1 323 patients with positive AMA and/or AMA-M2 detected for the first time were collected through the Information System of Peking University People′s Hospital. Among them, 183 were detected by indirect immunofluorescence assay, 431 were measured by immunoblotting, and 709 were determined by enzyme-linked immunosorbent assay (ELISA). Patients were divided into undiagnosed PBC group (non-PBC group, 973 cases) and newly diagnosed PBC group (new-PBC group, 350 cases including 268 cases of non-liver cirrhosis and 82 cases of liver cirrhosis); among 709 cases detected by ELISA, there were 567 cases in the non-PBC group and 142 cases in the new-PBC group (115 cases of non-liver cirrhosis PBC group and 27 cases of liver cirrhosis PBC group). Among 183 cases determined by indirect immunofluorescence assay, there were 118 cases in the non-PBC group and 65 cases in the new-PBC group. Among them 69 cases with low AMA titer (1∶40—1∶80) (53 cases of non-PBC group and 16 cases of new-PBC group), 95 cases with medium titer (1∶160—1∶320) (59 cases of non-PBC group and 36 cases of new-PBC group) and 19 cases with high titer (≥1∶640) (six cases of non-PBC group and 13 cases of new-PBC group). AMA levels among groups were compared, and its correlation with clinical serology and cirrhosis indicators of PBC including immunoglobulin (Ig)G, IgM, platelet, alanine aminotransferase (ALT), aspartate aminotransferase (AST), γ-glutamyltranspeptadase (GGT), alkaline phosphatase (ALP), serum total protein, serum albumin, total bilirubin (TBil), total cholesterol (TC), and aspartate aminotransferase to platelet ratio index (APRI) and fibrosis (Fib-4) was analysed. Mann-Whitney U test, Kruskal-Wallis test, and linear regression analysis were performed for statistical analysis. Results By ELISA method, the median titer of AMA-M2 of 709 patients was 53 RU/mL, the serum AMA and AMA-M2 levels of new-PBC group were both higher than those of non-PBC group (1∶320 vs. 1∶80, 180 RU/mL vs. 47 RU/mL), and the differences were statistically significant (χ2 = 14.111, Z = -7.531, both P 0.05). AMA-M2 value of patients in PBC with liver cirrhosis group was positively correlated with IgM level (r = 0.38, P = 0.039), but was not correlated with APRI and Fib-4 (all P > 0.05). The median of AMA value of 183 patients who underwent indirect immunofluorescence test was 1∶160. In non-PBC group, the IgM levels of patients with low, medium and high AMA titers gradually increased (the median levels were 1.2, 1.7 and 1.8 g/L, respectively); in new-PBC group, the levels of IgM, GGT and ALP of patients with low, medium and high AMA titers gradually increased (median IgM levels were 1.5, 3.7 and 4.1 g/L, respectively; GGT levels were 144,
目的探讨首次就诊的原发性胆管炎(PBC)患者抗线粒体抗体(AMA)水平与临床指标的相关性。方法收集2013年1月至2016年12月北京大学人民医院信息系统首次检测到AMA和(或)AMA- m2阳性患者1 323例的临床资料。其中间接免疫荧光法检测183例,免疫印迹法检测431例,酶联免疫吸附法(ELISA)检测709例。将患者分为未确诊PBC组(非PBC组,973例)和新确诊PBC组(新确诊PBC组,350例,其中非肝硬化268例,肝硬化82例);ELISA检测的709例患者中,无PBC组567例,新PBC组142例(其中无肝硬化PBC组115例,肝硬化PBC组27例)。间接免疫荧光法测定的183例患者中,非pbc组118例,新pbc组65例。其中低滴度(1∶40 ~ 1∶80)69例(非pbc组53例,新pbc组16例),中滴度(1∶160 ~ 1∶320)95例(非pbc组59例,新pbc组36例),高滴度(≥1∶640)19例(非pbc组6例,新pbc组13例)。比较各组间AMA水平,并分析其与PBC临床血清学及肝硬化指标免疫球蛋白(Ig)G、IgM、血小板、丙氨酸转氨酶(ALT)、天冬氨酸转氨酶(AST)、γ-谷氨酰转肽酶(GGT)、碱性磷酸酶(ALP)、血清总蛋白、血清白蛋白、总胆红素(TBil)、总胆固醇(TC)、天冬氨酸转氨酶与血小板比值指数(APRI)、纤维化(Fib-4)的相关性。采用Mann-Whitney U检验、Kruskal-Wallis检验和线性回归分析进行统计学分析。结果ELISA法检测709例患者血清AMA- m2滴度中位数为53 RU/mL,新发pbc组血清AMA、AMA- m2水平均高于非pbc组(1∶320 vs. 1∶80,180 RU/mL vs. 47 RU/mL),差异均有统计学意义(χ2 = 14.111, Z = -7.531, P均为0.05)。PBC合并肝硬化组患者AMA-M2值与IgM水平呈正相关(r = 0.38, P = 0.039),与APRI、Fib-4无相关性(均P > 0.05)。183例间接免疫荧光试验患者的AMA值中位数为1∶160。在非pbc组,低、中、高AMA滴度患者IgM水平逐渐升高(中位数分别为1.2、1.7、1.8 g/L);在新pbc组,低、中、高AMA滴度患者IgM、GGT、ALP水平逐渐升高(IgM水平中位数分别为1.5、3.7、4.1 g/L;GGT水平分别为144、182、317 U/L;ALP分别为137、168、221 U/L),差异均有统计学意义(χ2 =6.260、7.081、8.030、15.226,P均<0.05)。在非pbc组,男性血清AMA-M2中位水平低于女性(41 RU/L比50 RU/L),差异有统计学意义(Z = -2.945, P = 0.003)。在新发pbc组,男性血清AMA-M2中位水平有低于女性的趋势(113 RU/mL vs 206 RU/mL),但差异无统计学意义(P=0.257)。结论PBC患者血清AMA水平与多项临床指标相关,可能与病情严重程度有关。关键词:抗线粒体抗体;原发性胆管炎;肝硬化;临床意义
{"title":"Correlation between anti-mitochondrial antibodies and clinical serological and cirrhotic markers of primary biliary cholangitis","authors":"R. Jin, Xiaoxiao Wang, Lihua Wang, Hui Ma, Ji-lian Fang, Hao Wang, H. Rao, Lai Wei, B. Feng","doi":"10.3760/CMA.J.ISSN.0254-1432.2020.01.004","DOIUrl":"https://doi.org/10.3760/CMA.J.ISSN.0254-1432.2020.01.004","url":null,"abstract":"Objective \u0000To explore the correlation between the level of anti-mitochondrial antibody (AMA) and clinical indicators of first visited primary biliary cholangitis (PBC) patients with positive AMA. \u0000 \u0000 \u0000Methods \u0000From January 2013 to December 2016, the clinical data of 1 323 patients with positive AMA and/or AMA-M2 detected for the first time were collected through the Information System of Peking University People′s Hospital. Among them, 183 were detected by indirect immunofluorescence assay, 431 were measured by immunoblotting, and 709 were determined by enzyme-linked immunosorbent assay (ELISA). Patients were divided into undiagnosed PBC group (non-PBC group, 973 cases) and newly diagnosed PBC group (new-PBC group, 350 cases including 268 cases of non-liver cirrhosis and 82 cases of liver cirrhosis); among 709 cases detected by ELISA, there were 567 cases in the non-PBC group and 142 cases in the new-PBC group (115 cases of non-liver cirrhosis PBC group and 27 cases of liver cirrhosis PBC group). Among 183 cases determined by indirect immunofluorescence assay, there were 118 cases in the non-PBC group and 65 cases in the new-PBC group. Among them 69 cases with low AMA titer (1∶40—1∶80) (53 cases of non-PBC group and 16 cases of new-PBC group), 95 cases with medium titer (1∶160—1∶320) (59 cases of non-PBC group and 36 cases of new-PBC group) and 19 cases with high titer (≥1∶640) (six cases of non-PBC group and 13 cases of new-PBC group). AMA levels among groups were compared, and its correlation with clinical serology and cirrhosis indicators of PBC including immunoglobulin (Ig)G, IgM, platelet, alanine aminotransferase (ALT), aspartate aminotransferase (AST), γ-glutamyltranspeptadase (GGT), alkaline phosphatase (ALP), serum total protein, serum albumin, total bilirubin (TBil), total cholesterol (TC), and aspartate aminotransferase to platelet ratio index (APRI) and fibrosis (Fib-4) was analysed. Mann-Whitney U test, Kruskal-Wallis test, and linear regression analysis were performed for statistical analysis. \u0000 \u0000 \u0000Results \u0000By ELISA method, the median titer of AMA-M2 of 709 patients was 53 RU/mL, the serum AMA and AMA-M2 levels of new-PBC group were both higher than those of non-PBC group (1∶320 vs. 1∶80, 180 RU/mL vs. 47 RU/mL), and the differences were statistically significant (χ2 = 14.111, Z = -7.531, both P 0.05). AMA-M2 value of patients in PBC with liver cirrhosis group was positively correlated with IgM level (r = 0.38, P = 0.039), but was not correlated with APRI and Fib-4 (all P > 0.05). The median of AMA value of 183 patients who underwent indirect immunofluorescence test was 1∶160. In non-PBC group, the IgM levels of patients with low, medium and high AMA titers gradually increased (the median levels were 1.2, 1.7 and 1.8 g/L, respectively); in new-PBC group, the levels of IgM, GGT and ALP of patients with low, medium and high AMA titers gradually increased (median IgM levels were 1.5, 3.7 and 4.1 g/L, respectively; GGT levels were 144, ","PeriodicalId":10009,"journal":{"name":"中华消化杂志","volume":"11 1","pages":"16-22"},"PeriodicalIF":0.0,"publicationDate":"2020-01-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"84334162","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Activation of corticotropin-releasing hormone system in the locus ceruleus induces the visceral sensitivity of irritable bowel syndrome rats 激活蓝斑区促肾上腺皮质激素释放激素系统诱导肠易激综合征大鼠内脏敏感性
Pub Date : 2020-01-15 DOI: 10.3760/CMA.J.ISSN.0254-1432.2020.01.008
Xi Wang, M. Li, Yue Hu, Chunyan Dai, Yufei Fu, Weiyang Jin, Zhe Chen, B. Lyu
Objective To study the role of corticotropin-releasing hormone (CRH) system in locus ceruleus (LC) in irritable bowel syndrome (IBS) and to explore its molecular mechanism. Methods The IBS rat was established by maternal separation following with postnatal stress. The tissues sample of LC was obtained by micropunched nuclei. The expression of c-Fos, CRH and its receptors including corticotropin-releasing hormone receptor (CRHR) 1 and CRHR2 of rats’ LC tissues of control group and IBS group was detected by quantitative polymerase chain reaction(PCR). The expression of DNA methyltransferase (DNTM) 1, DNMT3a and DNMT3b at the mRNA level were also measured. In addition, the expression of histone methyltransferase ASH2-like protein (ASH2L) and SET and MYND domain containing 2 (SMYD2) was determined by Western blotting. T test was used for statistical analysis. Results The rectal pneumatic pressure of IBS group was lower than that of control group ((69.82±5.47) mmHg vs. (86.86±5.98) mmHg; 1 mmHg=0.133 kPa), however compared with that of control group, the expression of c-Fos at the mRNA level increased (2.11±0.44 vs.1.00±0.19), and the differences were statistically significant (t=6.215 and 2.321, P 0.05). Conclusions Maternal separation combined with postnatal stress affect the transcription of Crh gene in LC and cause the activation of the stress regulation network CRH and norepinephrine system, resulting in the increase of the visceral sensitivity of rats. The abnormal transcription of Crh gene may be related with SMYD2-mediated histone H3K36 methylation, but not related with the modification of DNA methylation. Key words: Irritable bowel syndrome; Locus ceruleus; Maternal separation stress; Corticotropin-releasing hormone system; Epigenetics
目的研究促肾上腺皮质激素释放激素(CRH)系统在肠易激综合征(IBS)蓝斑区(LC)中的作用,并探讨其分子机制。方法采用产后应激分离法建立IBS大鼠模型。用微孔核法获得LC的组织样品。采用定量聚合酶链反应(PCR)检测对照组和IBS组大鼠LC组织中c-Fos、CRH及其受体(促肾上腺皮质激素释放激素受体(CRHR) 1、CRHR2)的表达。同时检测DNA甲基转移酶(DNTM) 1、DNMT3a和DNMT3b mRNA水平的表达。Western blotting检测组蛋白甲基转移酶ash2样蛋白(ASH2L)和含SET和MYND结构域2 (SMYD2)的表达。采用T检验进行统计分析。结果肠易激综合征组直肠气压低于对照组((69.82±5.47)mmHg vs(86.86±5.98)mmHg;1 mmHg=0.133 kPa),但与对照组相比,mRNA水平上c-Fos表达增加(2.11±0.44 vs.1.00±0.19),差异有统计学意义(t=6.215和2.321,P 0.05)。结论母鼠分离联合产后应激可影响LC中Crh基因的转录,激活应激调节网络Crh和去甲肾上腺素系统,导致大鼠内脏敏感性升高。Crh基因的异常转录可能与smyd2介导的组蛋白H3K36甲基化有关,但与DNA甲基化修饰无关。关键词:肠易激综合征;蓝斑核;产妇分离压力;促肾上腺皮质激素释放激素系统;表观遗传学
{"title":"Activation of corticotropin-releasing hormone system in the locus ceruleus induces the visceral sensitivity of irritable bowel syndrome rats","authors":"Xi Wang, M. Li, Yue Hu, Chunyan Dai, Yufei Fu, Weiyang Jin, Zhe Chen, B. Lyu","doi":"10.3760/CMA.J.ISSN.0254-1432.2020.01.008","DOIUrl":"https://doi.org/10.3760/CMA.J.ISSN.0254-1432.2020.01.008","url":null,"abstract":"Objective \u0000To study the role of corticotropin-releasing hormone (CRH) system in locus ceruleus (LC) in irritable bowel syndrome (IBS) and to explore its molecular mechanism. \u0000 \u0000 \u0000Methods \u0000The IBS rat was established by maternal separation following with postnatal stress. The tissues sample of LC was obtained by micropunched nuclei. The expression of c-Fos, CRH and its receptors including corticotropin-releasing hormone receptor (CRHR) 1 and CRHR2 of rats’ LC tissues of control group and IBS group was detected by quantitative polymerase chain reaction(PCR). The expression of DNA methyltransferase (DNTM) 1, DNMT3a and DNMT3b at the mRNA level were also measured. In addition, the expression of histone methyltransferase ASH2-like protein (ASH2L) and SET and MYND domain containing 2 (SMYD2) was determined by Western blotting. T test was used for statistical analysis. \u0000 \u0000 \u0000Results \u0000The rectal pneumatic pressure of IBS group was lower than that of control group ((69.82±5.47) mmHg vs. (86.86±5.98) mmHg; 1 mmHg=0.133 kPa), however compared with that of control group, the expression of c-Fos at the mRNA level increased (2.11±0.44 vs.1.00±0.19), and the differences were statistically significant (t=6.215 and 2.321, P 0.05). \u0000 \u0000 \u0000Conclusions \u0000Maternal separation combined with postnatal stress affect the transcription of Crh gene in LC and cause the activation of the stress regulation network CRH and norepinephrine system, resulting in the increase of the visceral sensitivity of rats. The abnormal transcription of Crh gene may be related with SMYD2-mediated histone H3K36 methylation, but not related with the modification of DNA methylation. \u0000 \u0000 \u0000Key words: \u0000Irritable bowel syndrome; Locus ceruleus; Maternal separation stress; Corticotropin-releasing hormone system; Epigenetics","PeriodicalId":10009,"journal":{"name":"中华消化杂志","volume":"10 1","pages":"40-44"},"PeriodicalIF":0.0,"publicationDate":"2020-01-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"77550141","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
中华消化杂志
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1